AGENDA RADIOTERAPIA

 Charla Magistral: Dr. Iván Bobadilla
Retos en el tratamiento de Radioterapia en Colombia

1er BEST OF ASTRO - COLOMBIA 2021 - 26 DE FEBRERO 2021
Módulo: Cáncer de Mama
EXPOSITORES
Dra. Isabel Giraldo
Dra. Lina Arbelaez

Abstract 5 Cosmetic Outcome from Post Lumpectomy Whole Breast Irradiation (WBI) Versus Partial Breast Irradiation (PBI) on the NRG Oncology/NSABP B39-RTOG 0413 Phase III Clinical Trial

Abstract 85 Quantifying the Impact of Regional Lymph Node Irradiation on Lymphedema Risk in Breast Cancer Patients Treated with SLNB or ALND: Long- Term Results from a Prospective Screening Trial

Abstract 84 Prospective Phase II Clinical Trial of Hypofractionated Radiation in Breast Cancer Patients undergoing Comprehensive Nodal Irradiation for Node Positive Disease

Abstract 87 A Prospective Phase I trial of Concurrent Cisplatin (CIS) and Radiation Therapy (RT) in Women with Stage II and III Triple-negative Breast Cancer (TNBC)

Abstract 83 Post Mastectomy Radiation Therapy in HER2/ neu Positive Breast Cancer: Analysis of the HERA trial

Abstract 18 Impact of Adjuvant Trastuzumab on Locoregional Failure Rates in the NCCTG N9831 (Alliance) Study

Módulo: Cáncer de Próstata
EXPOSITORES
Dr. Oscar Abuchaibe
Dr. Javier Cifuentes

Abstract 77 A Phase III Multi-Centre Randomised Trial comparing adjuvant versus early salvage Radiotherapy following a Radical Prostatectomy: Results of the TROG 08.03 and ANZUP “RAVES” Trial

Abstract 112 Accelerating Prostate Stereotactic Ablative Body Radiotherapy (SABR): Efficacy and Toxicity of a Randomized Phase II Study of 11 Versus 29 Days Overall Treatment Time (PATRIOT Study; ClinicalTrials.gov NCT01423474)

Abstract 115 A Biochemical Definition of Cure Following Brachytherapy for Prostate Cancer: A Multi-Institution International Study

Abstract 111 Patient Reported Acute Toxicity in PACE-B,an International Phase III Randomised Controlled Trial Comparing Stereotactic Body Radiotherapy to Conventionally Fractionated or Moderately Hypofractionated Radiotherapy (CFMHRT) for Localised Prostate Cancer

Abstract 113 High Dose-Rate Prostate Brachytherapy as Monotherapy: a Single Fraction May Not be Enough

Abstract 81 Radical Prostatectomy, External Beam Radiotherapy, or External Beam Radiotherapy With Brachytherapy Boost: Comparison of Outcomes in A Multi-Institutional Analysis of 4,086 Patients with High-Risk Prostate Cancer

 Dr. Raymond Mailhot - University of Florida USA - Protonterapia en Pediatria
 Dra. Nathalie González - CDD REP DOM - Radioterapia en Ca de mama triple negativo 
                                Simposio Astra Zeneza - Dra. Monika Blake - Hospital ABC México
         Régimen PACIFIC: Redefiniendo el rol de radioterapia en cáncer de pulmón EIII no resecable
Dr. César Alturo - Centro Javeriano de Oncologia
Retos y estrategias en el manejo de la mucositis
Módulo: Hematología
EXPOSITORES
Dra. Yurany Bermúdez
Dr. Ricardo Cendales Duarte

Abstract 1 PET-Guided Treatment of Early-Stage Favorable Hodgkin Lymphoma: Final Results of the International, Randomized Phase 3 Trial HD16 by the GHSG

Abstract 68 Long-Term Outcomes for Patients With Limited Stage Follicular Lymphoma: An Update of a Population-based Study

Abstract 69 Radiotherapy in Early-Stage Gastric MALT: Improved Survival without Increased Cardiac Death

Abstract 1281 Quality of Life Improvement Following Low-Dose Total Skin Electron Beam Therapy in Patients with Mycosis Fungoides or Sezary Syndrom

Abstract 1291 Accelerated Fractionated Compared to Conventional Fractionated Salvage Radiation Therapy Improves Outcomes in Salvage Chemotherapy Refractory Diffuse Large B-CellLymphoma

Abstract 139 Is Radiotherapy Adequate Treatment for Patients not in Complete Metabolic Response after First-Line Chemotherapy for DLBCL?

Módulo: Cáncer Ginecológico
EXPOSITORES
Dra. Ilse Vásquez
Dra. Elsa Cuervo

Abstract 2 Patterns of Recurrence and Survival in the Randomized Portec-3 Trial of Chemoradiotherapy for High-Risk Endometrial Cancer

Abstract 101 IMRT Improves Late Toxicity Compared to Conventional RT: An Update on NRG Oncology-RTOG 1203

Abstract 104 Sexual Activity and Vaginal Functioning in Patients with Locally Advanced Cervical Cancer following Definitive Radiochemotherapy and Image-Guided Adaptive Brachytherapy (EMBRACE Study)

Abstract 105 Comparison of Concurrent Cisplatin Chemoradiotherapy Plus Adjuvant Chemotherapy Versus Concurrent Chemoradiotherapy Alone in Locally Advanced Cervical Cancer

Abstract 1237 Definitive External Beam Radiation Therapy With Stereotactic Body Radiation Therapy Boost for FIGO Stage IB - IIB Cancer of the Cervix: Minimum 5-Year Disease Control, Toxicity and Quality of Life Outcomes From a Phase 2 Trial

Abstract 1242 Regional Control and Dose-Response for Chemoradiotherapy in Locally-Advanced Endometrial Cancer

Abstract 1238 Stage III Uterine Serous Carcinoma: Improved Outcomes in the Modern Era with Multi-Modality Treatment

Módulo: Cáncer de Pulmón
EXPOSITORES
Dr. Alejandro González
Dr. Juan Carlos Galvis

Abstract 71 The Incidence and Location of Brain Metastases Following HA-PCI Compared with Standard PCI in Small Cell Lung Cancer (SCLC): A Phase III Trial

Abstract 72 Phase III Trial of Prophylactic Cranial Irradiation with or without Hippocampal Avoidance for SMALLCELL LUNG Cancer

Abstract 90 Accelerated Hypofractionated CRT Followed by SABR Boost (HyCRT-SABR) for Locally Advanced Unresectable NSCLC: A Prospective Phase II Radiation Dose-Escalation Study

Abstract 91 Left Coronary Artery Dose Exposure Predicts Major Adverse Cardiac Events in Coronary Heart Disease Negative Lung Cancer Patients

Abstract 92 The Dutch Lung Cancer Audit-Radiotherapy  (DLCA-R): Real-World Data on Elderly Stage III Non-Small Cell Lung Cancer Treated with Definitive Chemoradiation

1er BEST OF ASTRO - COLOMBIA 2021 - 26 DE FEBRERO 2021
Módulo: Cáncer de Cabeza y Cuello
EXPOSITORES
Dr. Guillermo Potdevin
Dr. Sergio Cafiero

Abstract 106 Radiotherapy vs. Trans-Oral Robotic Surgery for Oropharyngeal Squamous Cell Carcinoma (OPSCC): Results of a Randomized Trial

Abstract 107 A Phase II Trial of Alternative Volumes of Oropharyngeal Irradiation for Deintensification (AVOID): Omission of the Resected Primary Tumor Bed for Squamous Cell Carcinoma of the Oropharynx

Abstract 31 Reduction of Radiotherapy Dose to the Elective Neck in Head and Neck Squamous Cell Carcinoma; Update of the Long-Term Tumor Control of a Randomized Clinical Trial

Abstract 108 Recurrence and Quality-of-Life FollowingElective Nodal Volume and Dose De-Escalation for Oropharyngeal and Laryngeal Cancer: Initial Results from the Infield Trial

Abstract 109 Randomized Clinical Trial on 7-days-aweek Postoperative Radiotherapy vs. Concurrent Postoperative Radio-chemotherapy in Locally Advanced Cancer of the Oral Cavity/Oropharynx

Abstract LBA 10 NRG-HN002 A Randomized Phase II Trial for Patients with p16-Positive, Non- Smoking-Associated, Locoregionally Advanced Oropharyngeal Cancer

Módulo: Sistema Nervioso Central
EXPOSITORES
Dr. Eduardo Guerrero
Dr. José Alejandro Esguerra

Abstract 3 Radiosurgery Compared to External Beam Radiotherapy for Localized Spine Metastasis: Phase III Results of NRG Oncology/RTOG 0631

Abstract 23 Significant Preservation of Neurocognitive Function (NCF) and Patient Reported Symptoms with Hippocampal Avoidance (HA) during Whole-Brain Radiotherapy (WBRT) for Brain Metastases: Final Results of NRG Oncology CC001

Abstract 161 Comprehensive Prognostic and Predictive Molecular Subgroup Analysis within the High-risk Treatment Arms of NRG Oncology/RTOG 9802: A Phase III Trial of RT versus RT + PCV in High-risk Low-grade Gliomas

Abstract 20 Prospective Phase I Dose Escalation Study for Neoadjuvant Radiosurgery for Large Brain Metastases

Abstract 1056 A Single Blind Randomized Controlled Trial of Hippocampal Avoidance on Neurocognitive Outcomes After Conformal Whole Brain Radiotherapy for Brain Metastases: An Initial Analysis 

Abstract MO_4_2176 Leucencephalopathy after Prophylactic Whole Brain Irradiation with or without Hippocampal Sparing: A Long-Term MRI Analysis

Módulo: Inmunoterapia
EXPOSITORES
Dr. Garvin González

Abstract 73 A Prospective Single Arm Phase I/II Study: Consolidative Ipilimumab and Nivolumab with Thoracic Radiotherapy after Platinum Based Chemotherapy for Patients with Extensive-Stage Small Cell Lung Cancer

Abstract 37 A Pilot Study of Stereotactic Body Radiotherapy (SBRT) Combined with a PD-L1 Antibody Durvalumab (D) and a CTLA-4 antibody Tremelimumab (T) To Treat Metastatic Anaplastic Thyroid Cancer (ATC)

Abstract 160 Randomized Phase II Trial of Re-Irradiation and Concurrent Bevacizumab versus Bevacizumab Alone as Treatment for Recurrent Glioblastoma (NRG Oncology/RTOG 1205): Initial Outcomes and RT Plan Quality Report

  Dr. Carlos Vargas - Mayo Clinic, USA - Protonterapia en Cáncer de Próstata
 Dra. Monika Blake - Hospital ABC, México  
Abordaje del paciente con Cáncer de Próstata: 10 años de sobrevida
Módulo: Radioterapia Paliativa
EXPOSITORA
Dra. Maria Cristina Maldonado

Abstract 148 Quality of Life Outcomes after Stereotactic Ablative Radiotherapy (SABR) vs. Standard of Care Palliative Treatments: A Secondary Analysis of the SABR-COMET Randomized Trial

Abstract  98 A Prospective Randomized Phase II Trial of Single-Fraction versus Multi-Fraction Stereotactic Spine Radiosurgery for Spinal Metastases: An Initial Analysis

Abstract 100 Single-Fraction Stereotactic versus Conventional Multifraction Radiation for Predominantly Non-Spine Bone Metastases: A Randomized Phase II Trial

Abstract 149 Pre-Treatment and Early Post-Radiotherapy PET Metabolic Metrics Predict Probability of Local Relapse in Oligometastases

Abstract 153 A Volumetric Dosimetry Analysis of Vertebral Body Fracture Risk after Spine Stereotactic Radiosurgery

Abstract LBA 3 Primary Outcomes of a Phase II Randomized Trial of Observation versus Stereotactic Ablative Radiation for Oligometastatic Prostate Cancer (ORIOLE)

Módulo: Cáncer Gastrointestinal
EXPOSITORES
 Dr. David Gómez
Dr. Aurelio Angulo

Abstract 175 A Pilot Study of Neoadjuvant FOLFIRINOX followed by Chemoradiation for Gastric and Gastroesophageal Cancer: Preliminary Results and Prognostic Implications of ctDNA

Abstract 176 Patterns of Recurrence in the Critics Gastric Cancer Trial: Results from Intention-to-Treat and per-Protocol Analyses

Abstract 217 ctDNA As a Potential Prognostic Marker for Locally Advanced Rectal Cancer Patients Receiving Neoadjuvant Chemo-Radiation Therapy on Disease-Free Survival (DFS)

Abstract 219 Improved Stratification for Risk of Early Metastases by Baseline Circulating Tumor Cell Counts for Locally Advanced Rectal Cancer in Neoadjuvant Setting: an Exploratory Analysis from a Phase III trial

Abstract 227 Multicenter Phase II Study of Stereotactic Ablative RadioTherapy for Hepatocellular Carcinoma ≤ 5 cm (KROG 12-02)

Abstract 229 Evaluating the Impact of Combination of Nivolumab and Ipilimumab to Liver/Lung SBRT on Local Control for Colorectal and Pancreatic Cancer: A Pooled Analysis of Two Prospective Trials

© 2019 by Lacort Medical. All rights reserved

  • LinkedIn Social Icon
  • Twitter Social Icon